Pharma Archives - Page 94 of 96 - Boston Life Sciences Times

Pharma

Novavax Covid-19 vaccine found 89.3% effective

Life Sciences Times - January 29, 2021 0

Pharma

J&J single-shot Covid-19 vaccine shows 66% efficacy overall

Life Sciences Times - January 29, 2021 0

Pharma

Pfizer-BioNTech Covid vax neutralises UK, South Africa variants

Life Sciences Times - January 28, 2021 0

Pharma

Why so many people overuse antibiotics

Life Sciences Times - January 28, 2021 0

Pharma

200 million extra doses: Biden-led Covid-19 turnaround kicks off

Life Sciences Times - January 27, 2021 0

Pharma

Merck Presents Interim Findings from Phase 2a Clinical Trial Evaluating Investigational Once-Monthly Oral Islatravir for the Prevention of HIV-1 Infection

Life Sciences Times - January 26, 2021 0

Pharma

Moderna says its Covid-19 vaccine works against new variants

Life Sciences Times - January 25, 2021 0

Pharma

Australia gives provisional approval to Pfizer Covid-19 vaccine

Life Sciences Times - January 25, 2021 0

Pharma

Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic Hepatitis B Virus

Life Sciences Times - January 12, 2021 0

Pharma

Receptor Life Sciences Receives FDA Guidance for Development of RLS 103, Designed for the Treatment of Acute Panic Attack

Life Sciences Times - January 11, 2021 0

Pharma

Affinivax Announces $226 Million Series C Financing to Advance Its Pipeline of Novel MAPS™ Vaccines Targeting Infectious Diseases

Life Sciences Times - January 8, 2021 0

Pharma

New Dermatology Company Resilia Pharmaceuticals Begins Operations

Life Sciences Times - December 28, 2020 0

1...939495 96 Page 94 of 96

Mirador Therapeutics Licenses Long-Acting Anti-C5a Antibody from Kira Pharmaceuticals

July 17, 2026

Bayer and Henry Ford Health Partner to Expand Patient Access to Clinical Trials

July 17, 2026

Inflammasome Therapeutics Reports Positive Phase 2 Results for K8 in Geographic Atrophy

July 17, 2026

Aqemia and Sanofi Expand AI-Driven Drug Discovery Collaboration

July 17, 2026

Pharma

Takeda’s Zasocitinib Shows High Skin-Clearance Rates Across Hard-to-Treat Psoriasis Sites

Rectify Pharmaceuticals Names Constantine Chinoporos Executive Chairman

Keytruda Improves Progression-Free Survival in Phase 3 Endometrial Cancer Trial

Alkermes Reports Sustained Wakefulness Improvements With Alixorexton in Narcolepsy Study

EMD Serono Gets FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients

Most Read

Mirador Therapeutics Licenses Long-Acting Anti-C5a Antibody from Kira Pharmaceuticals

Bayer and Henry Ford Health Partner to Expand Patient Access to Clinical Trials

Inflammasome Therapeutics Reports Positive Phase 2 Results for K8 in Geographic Atrophy

Aqemia and Sanofi Expand AI-Driven Drug Discovery Collaboration

EDITOR PICKS

Inflammasome Therapeutics Reports Positive Phase 2 Results for K8 in Geographic Atrophy

Syntis Bio Reports Positive Initial Phase 1/1b Data for Obesity Drug SYNT-101

AdvanCell Raises $315 Million to Advance Targeted Alpha Cancer Therapies

THIS WEEK'S STORIES

Draig Therapeutics Raises $65 Million to Advance Neuropsychiatric Drug Pipeline

Syntis Bio Reports Positive Initial Phase 1/1b Data for Obesity Drug SYNT-101

Aqemia and Sanofi Expand AI-Driven Drug Discovery Collaboration

POPULAR CATEGORY

ABOUT US

FOLLOW US